Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Phase III study shows efficacy of becaplermin treatment for diabetic neuropathic ulcers

July 8, 1998

Dusa submits NDA for Levulan PDT of actinic keratoses

July 6, 1998

Scientifically tested hair loss treatment introduced in Canada

July 1, 1998

Kyowa Hakko prepares new compounds for pruritus, asthma

July 1, 1998

5alpha-Reductase inhibitor from Merck with potential in treating acne

June 30, 1998

Phytopharm's alopecia treatment enters phase II testing

June 26, 1998

YPE-01: a new diarylheptanoid effective against dermal inflammation

June 23, 1998

Allergan continues to strengthen its position in retinoid R&D

June 22, 1998

Phase III results reported for HyClinda

June 22, 1998

Celtrix's SomatoKine shows promise in treating protein wasting

June 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...